Showing results (401-410 of 478) with videos related to

Sort By:
Pageof 48
Lancet (London, England)|January 29, 2002
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trialsEric Boersma, Robert A Harrington, David J Moliterno, et al.
Plos Genetics|September 15, 2010
Longitudinal genome-wide association of cardiovascular disease risk factors in the Bogalusa heart studyErin N Smith, Wei Chen, Mika Kähönen, et al.
Scientific Reports|September 27, 2017
A Whole Blood Molecular Signature for Acute Myocardial InfarctionEvan D Muse, Eric R Kramer, Haiying Wang, et al.
European Heart Journal|December 25, 2004
Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trialsMarino Labinaz, Jasmine Mathias, Karen Pieper, et al.
Lancet (London, England)|September 21, 2002
Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up studyDavid J Moliterno, Steven J Yakubov, Peter M DiBattiste, et al.
Circulation|May 22, 2002
Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET TrialGregg W Stone, David J Moliterno, Michel Bertrand, et al.
BMC Medical Education|November 4, 2024
Co-design and evaluation of an audio podcast about sustainable development goals for undergraduate nursing and midwifery studentsTara Anderson, Patrick Stark, Stephanie Craig, et al.
Circulation|October 8, 2008
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular riskJohn W Eikelboom, Graeme J Hankey, Jim Thom, et al.
European Heart Journal|September 17, 2009
Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trialsMarco Valgimigli, Giuseppe Biondi-Zoccai, Matteo Tebaldi, et al.
The American Journal of Cardiology|February 22, 2005
Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials)Abdallah G Rebeiz, Per Johanson, Cindy L Green, et al.
Pageof 48